Model for End-stage Liver Disease and Model for End-stage Liver Disease-Na Scores Predict Both Before-Listing and Wait-List Mortality

被引:9
|
作者
Yamashiki, N. [2 ]
Sugawara, Y. [1 ]
Tamura, S.
Kaneko, J.
Nojiri, K. [3 ]
Aoki, T.
Sakamoto, Y.
Hasegawa, K.
Koike, K. [2 ]
Kokudo, N.
机构
[1] Univ Tokyo, Artificial Organ & Transplantat Div, Dept Surg, Grad Sch Med,Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo 1138655, Japan
[3] Univ Tokyo, Organ Transplantat Serv, Grad Sch Med, Tokyo 1138655, Japan
关键词
TRANSPLANTATION; MELD;
D O I
10.1016/j.transproceed.2012.01.037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Due to the organ shortage, many patients die without transplantation, even before completing an evaluation for candidacy. We analyzed outcomes after patient referral and factors associated with mortality both before and after listing for cadaveric donor liver transplantation. Methods. We analyzed 132 consecutive patients who were evaluated for candidacy for cadaveric donor liver transplantation between 2003 and 2010. Results. The study included 69 men and 63 women of median age 49 years (range, 1-65). Etiologies of diseases were acute hepatic failure (n = 19), liver cirrhosis due to hepatitis B or C (n = 36), primary biliary cirrhosis (n = 19), nonviral cirrhosis (n = 14), hepatocellular carcinoma (n = 13), or other causes (n = 31). After evaluation for candidacy, we listed 68 (52%), subjects whereas 24 (18%) died before listing. Factors affecting death before listing were the levels of albumin (P < .001), bilirubin (P < .001), sodium (P < .001), international normalized ratio (INR; P < .001), Model for End-stage Liver Disease (MELD) score (P < .001), MELD-Na score (P < .001), and Child-Pugh-Turcotte (CPT) score (P < .001). Based on multivariate Cox regression analysis, MELD score (hazard ratio [HR] 1.201, P = .017), MELD-Na score (HR 1.244, P = .014), CPT score (HR 1.468, P = .033), and INR (HR 0.491, P = .027) were independently associated with death before listing. Among 68 listed candidates, 11(16%) underwent transplantation, whereas 29 (43%) died without transplantation. Based on multivariate Cox regression analysis, MELD score (HR 1.102, P = .001), MELD-Na score (HR 1.128, P = .001), and CPT score (HR 1.282, P = .038) independently predicted wait-list mortality. All 11 patients who underwent cadaveric liver transplantation were alive at 29 months (range, 1-55) after transplantation. Conclusions. Patients with a higher MELD, higher MELD-Na, and higher CPT score at referral were at greater risk for death without transplantation, especially before listing. Evaluation for transplantation candidacy is a time-consuming process. Therefore, earlier referral is mandatory to achieve successful listing for transplantation.
引用
收藏
页码:389 / 392
页数:4
相关论文
共 50 条
  • [1] End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates
    Sharma, Pratima
    Schaubel, Douglas E.
    Gong, Qi
    Guidinger, Mary
    Merion, Robert M.
    HEPATOLOGY, 2012, 55 (01) : 192 - 198
  • [2] The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
    Kim, Jun Jae
    Kim, Jeong Han
    Koo, Ja Kyung
    Choi, Yun Jung
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (01) : 47 - 55
  • [3] The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study
    Duan, Fangfang
    Liu, Chen
    Zhai, Hang
    Quan, Min
    Cheng, Jun
    Yang, Song
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (10)
  • [4] Clinically Relevant Differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-Sodium Scores
    Garritsen, Rhiana
    Tintu, Andrei
    Metselaar, Herold
    Kazemier, Geert
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1903 - 1903
  • [6] Model for end-stage liver disease scores do not predict liver transplantation waiting list morbidity
    Cowling, T
    Jennings, LW
    Ueno, T
    Martin, P
    Sanchez, EQ
    Chinnakotla, S
    Randall, H
    Dawson, S
    Goldstein, RM
    Klintmalm, GB
    Levy, MF
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 516 - 516
  • [7] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [8] Model for End-stage Liver Disease
    Singal, Ashwani K.
    Kamath, Patrick S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (01) : 50 - 60
  • [9] Reply: Clinically Relevant Differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease-Sodium Scores
    Xiol, Xavier
    Castellote, Jose
    Fuentes-Arderiu, Xavier
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1904 - 1904
  • [10] The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada
    Renfrew, Paul Douglas
    Quan, Hude
    Doig, Christopher James
    Dixon, Elijah
    Molinari, Michele
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 25 (07) : 359 - 364